Blood substitutes

被引:25
作者
Winslow, RM
机构
[1] Sangart Inc, San Diego, CA 92121 USA
[2] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA
关键词
D O I
10.1097/00062752-200203000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Blood substitutes are solutions intended to replace transfusion of banked red blood cells. Several variations of products based on either hemoglobin (animal or human) or perfluorocarbon emulsions are in advanced stages of clinical development. The need for such products is pressing as shortages of banked blood worsen and awareness of the dangers of blood transfusion increases. Animal and human studies with these cell-free oxygen carriers have led to new concepts of how oxygen is delivered to tissue and how the microcirculation is regulated. Although development of products is exciting and timely, understanding how they function to perfuse and oxygenate tissue could be at least as important. Because cell-free oxygen carriers will perfuse every organ of the body, their effects are far-reaching, and the transition from the laboratory to the bedside can be expected to be slow and deliberate. Comparison of oxygen carriers with more traditional starch-based products provides new insight into the interaction of oxygen transport, microvascular perfusion, and blood volume expansion. Curr Opin Hematol 2002, 9:146-151 (C) 2002 Lippincott Williams Wilkins, Inc.
引用
收藏
页码:146 / 151
页数:6
相关论文
共 55 条
[1]   Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy? A research perspective - Editorial comment [J].
Alayash, AI .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2001, 29 (01) :1-3
[2]  
Ali AA, 2001, ANESTH ANALG, V92, P863
[3]  
Bäumler H, 2001, BIORHEOLOGY, V38, P39
[4]  
Berkenstadt H, 2001, ANESTH ANALG, V92, P984
[5]   Plasma from aged stored red blood cells delays neutrophil apoptosis and primes for cytotoxicity: Abrogation by poststorage washing but not prestorage leukoreduction [J].
Biffl, WL ;
Moore, EE ;
Offner, PJ ;
Ciesla, DJ ;
Gonzalez, RJ ;
Silliman, CC .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2001, 50 (03) :426-431
[6]   Hemoglobin based oxygen carriers at a cross road: The old paradigms must be abandoned and much more basic science investigation is necessary [J].
Bucci, E .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2001, 29 (04) :VII-X
[7]  
BURHOP KE, 2001, ARTIF CELL BLOOD SUB, V29, P101
[8]  
Burris D, 2001, ANN CHIR GYNAECOL, V90, P76
[9]   Vasoconstrictive response of rat mesenteric arterioles following infusion of cross-linked, polymerized, and conjugated hemoglobin solutions [J].
Caron, A ;
Malfatti, E ;
Aguejouf, O ;
Faivre-Fiorina, B ;
Menu, P .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2001, 29 (01) :19-30
[10]   Extreme normovolemic hemodilution: How low can you go and other alternatives to transfusion? [J].
Coursin, DB ;
Monk, TG .
CRITICAL CARE MEDICINE, 2001, 29 (04) :908-910